PEMBROLIZUMAB | B125514 | MERCK SHARP DOHME
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Sep. 4, 2026 | Active | Computed |
| 7-Year Orphan | Jan. 25, 1931 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12441780(composition) · relevance 90/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Top 50 of 173 AI-discovered patents by relevance.
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
| C.D. Cal. | 2016-07-07 | Terminated 2017-05-05 | — | |
| D.N.J. | 2016-01-22 | Terminated 2017-03-29 | — | |
| NVD | 2015-10-28 | Terminated 2016-02-24 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.